SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-19-001687
Filing Date
2019-03-13
Accepted
2019-03-13 08:01:35
Documents
74
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f10k_031219p.htm 10-K 1416108
2 EXHIBIT 21.1 exh_211.htm EX-21.1 1694
3 EXHIBIT 23.1 exh_231.htm EX-23.1 4328
4 EXHIBIT 31.1 exh_311.htm EX-31.1 9602
5 EXHIBIT 31.2 exh_312.htm EX-31.2 9935
6 EXHIBIT 32.1 exh_321.htm EX-32.1 6133
13 GRAPHIC proportionpatent.jpg GRAPHIC 35202
14 GRAPHIC secondarypatency.jpg GRAPHIC 32282
15 GRAPHIC fistulause.jpg GRAPHIC 35832
16 GRAPHIC graph_1.jpg GRAPHIC 20118
  Complete submission text file 0001171843-19-001687.txt   5225445

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE prto-20181231.xml EX-101.INS 797381
8 XBRL SCHEMA FILE prto-20181231.xsd EX-101.SCH 54406
9 XBRL CALCULATION FILE prto-20181231_cal.xml EX-101.CAL 41357
10 XBRL DEFINITION FILE prto-20181231_def.xml EX-101.DEF 353671
11 XBRL LABEL FILE prto-20181231_lab.xml EX-101.LAB 318197
12 XBRL PRESENTATION FILE prto-20181231_pre.xml EX-101.PRE 383372
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36694 | Film No.: 19677121
SIC: 2836 Biological Products, (No Diagnostic Substances)